Welwyn Garden City, UK (28th May 2012) Cresset, innovative provider of software and services for molecule designers, will be exhibiting on booth 409 at the American Chemical Society (ACS) National Meeting and Exposition which takes place in Philadelphia, PA, USA on August 19th – 23rd 2012.
Cresset will also be presenting as follows:
Computation Tools for Medicinal Chemists: Increasing the Dimensions of Drug Discovery
by Dr Robert Scoffin, Chief Executive Officer
Session: When Chemists and Computers Collide: Putting Cheminformatics in the Hands of Medicinal Chemists
August 19, 2012 from 10:15 am to 10:45 am; Philadelphia Marriott Downtown, Room 302/303
Identifying Novel Bioisosteres
by Dr Tim Cheeseright, Director of Products
Session: Bioisosteres Redux: Strategic Deployment in the Design and Development of Drug Candidates
August 22, 2012 from 9:10 am to 9:50 am; Pennsylvania Convention Center, Room Ballroom IV
Optimising your leads for potency AND drug-likeness – how to have it all
by Dr Robert Scoffin, Chief Executive Officer
Session: Optibrium StarDrop User Group and Workshop
August 22, 2012 from 12:00 pm to 14:30 pm; Pennsylvania Convention Center, Room 202A
Disruptive Technology for Chemical Patent Fortification
by Dr Rae Lawrence, Technical Sales Manager
Session: The Many Faces of CHAL: Where Chemistry Meets the Law
August 23, 2012 from 4:25 pm to 4:50 pm; Pennsylvania Convention Center, Room 113 C
Cresset CEO, Dr Robert Scoffin, said, “We are delighted to be participating in this event again. The ACS national meeting attracts chemists from around the world and enables them to learn about cutting edge technologies, such as our range of next generation chemistry software and services. Each of our presentations will present thought-provoking and enlightening methods for research. We hope to see you there to demonstrate how Cresset’s tools can set your company on the fast track to novel chemistry.”
Meeting the needs of computational and medicinal chemists, Cresset’s suite of next generation chemistry software comprises: forgeV10 a powerful computational suite to understand SAR and design; torchV10 an intuitive design and 3D SAR tool for medicinal chemists; torchV10lite a free 3D molecule viewing, editing and drawing tool; blazeV10 an amazing ligand based virtual screening tool; sparkV10 an exciting and powerful way of generating novel and diverse structures.
Scientists interested in Cresset’s next generation software can download free demos from the company’s website.
For further information on the complete range of software and services available from Cresset, please visit us on booth 409 at the ACS National Meeting and Exposition, visit www.cresset-group.com, follow Cresset on Twitter (@cressetgroup) or join the LinkedIn group.
About Cresset Group Ltd
Cresset develops software for calculating and comparing the molecular field characteristics of chemical compounds. Field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s customers to find more interesting, novel and relevant results than other methods. Cresset’s fields provide a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com
